Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 3/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | S100A4 | P26447 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30661156 | 1.00 | MAPT (0.37) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL18904939 | 0.92 | MAPT (0.34) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL1172933 | 0.83 | MAPT (0.46) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL20015776 | 0.79 | MAPT (0.34) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL470766 | 0.79 | ALDH1A1 (0.38) | MAPTALDH1A1KMT2AMEN1GAA | |
| SCHEMBL16579336 | 0.79 | MAPT (0.39) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL22109070 | 0.78 | ALDH1A1 (0.31) | MAPTALDH1A1GPR35 | |
| SCHEMBL14570582 | 0.77 | MAPT (0.37) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL13064298 | 0.77 | ALDH1A1 (0.40) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL20015768 | 0.77 | MAPT (0.33) | MAPTALDH1A1KMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4242216-A2 | ELECTRONIC DEVICE AND COMPOUND | Novaled GmbH (DE) | 2023-09-13 | — | — | EP | disclosed |
| US-10941144-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-10840456-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-11-17 | — | — | US | disclosed |
| EP-3667752-A1 | ELECTRONIC DEVICE AND COMPOUND | Novaled GmbH (DE) | 2020-06-17 | — | — | EP | disclosed |
| EP-2724388-B1 | ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2020-03-11 | — | — | EP | disclosed |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-10403824-B2 | Electronic device and compound | NOVALED GMBH (DE) | 2019-09-03 | — | — | US | disclosed |
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-21 | — | — | US | disclosed |
| US-20180179206-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD., (JP) | 2018-06-28 | — | — | US | disclosed |
| US-20170155047-A1 | Electronic Device and Compound | NOVALED GMBH (DE) | 2017-06-01 | — | — | US | disclosed |
| US-9502660-B2 | Electronic device and compound | NOVALED GMBH (DE) | 2016-11-22 | — | — | US | disclosed |
| EP-2614047-B1 | COMPOUNDS FOR ORGANIC PHOTOVOLTAIC DEVICES | NOVALED AG (DE) | 2016-10-26 | — | — | EP | disclosed |
| US-20140182681-A1 | Electronic Device and Compound | NOVALED GMBH (DE) | 2014-07-03 | — | — | US | disclosed |
| US-20140144509-A1 | Compounds for Organic Photovoltaic Devices | NOVALED AG (DE) | 2014-05-29 | — | — | US | disclosed |
| US-20140144509-A1 | Compounds for Organic Photovoltaic Devices | NOVALED AG (DE) | 2014-05-29 | — | — | US | disclosed |
| WO-2012031735-A1 | COMPOUNDS FOR ORGANIC PHOTOVOLTAIC DEVICES | NOVALED AG (DE) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180179206-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | L1CAM, ESR1, CHRM1 | MAPT 1871/4885ALDH1A1 83/4885KMT2A 1458/4885 |
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | MAPT 2451/4885ALDH1A1 404/4885KMT2A 1284/4885 |
| US-10403824-B2 | Electronic device and compound | BRIX1, C9, C1S | MAPT 4822/4885ALDH1A1 859/4885KMT2A 4323/4885 |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | PIEZO1, LEF1, L1CAM | MAPT 2451/4885ALDH1A1 404/4885KMT2A 1284/4885 |
| US-20170155047-A1 | Electronic Device and Compound | BRIX1, C9, C1S | MAPT 4822/4885ALDH1A1 859/4885KMT2A 4323/4885 |
| US-10941144-B2 | Organic electroluminescence device and electronic device | L1CAM, ESR1, CHRM1 | MAPT 1871/4885ALDH1A1 83/4885KMT2A 1458/4885 |
| US-10840456-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | L1CAM, PIEZO1, LEF1 | MAPT 932/4885ALDH1A1 21/4885KMT2A 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.